[Clinical studies of cis-diamminedichloroplatinum (CDDP) nephrotoxicity--influence of aging and urinary diversion].
Suzuki
K
K
Tajima
A
A
Aso
Y
Y
Ono
Y
Y
Ohshima
S
S
Fujita
T
T
Naide
Y
Y
Ariyoshi
Y
Y
Fukushima
M
M
Ohta
K
K
D000293:Adolescent; D000328:Adult; D000368:Aged; D000375:Aging; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D002945:Cisplatin / Q000009:adverse effects*; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007668:Kidney / Q000187:drug effects*; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D017663:Peplomycin; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*; D014547:Urinary Diversion
D001761:Bleomycin; D017663:Peplomycin; D004317:Doxorubicin; D002945:Cisplatin